List of Tables
    Table 1. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth Rate Comparison by Specification (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Potassium Sodium Dehydroandrographolide Succinate for Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Sites and Area Served
    Table 11. Manufacturers Potassium Sodium Dehydroandrographolide Succinate for Injection Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Potassium Sodium Dehydroandrographolide Succinate for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Potassium Sodium Dehydroandrographolide Succinate for Injection as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region (2017-2022) & (K Units)
    Table 16. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region (2017-2022)
    Table 17. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Region (2017-2022)
    Table 19. North America Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)
    Table 20. North America Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)
    Table 21. North America Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)
    Table 23. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)
    Table 25. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)
    Table 33. Latin America Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)
    Table 39. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification (2017-2022) & (K Units)
    Table 40. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)
    Table 41. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Specification (2017-2022) & (US$ Million)
    Table 42. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Share by Specification (2017-2022)
    Table 43. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Price by Specification (2017-2022) & (US$/Unit)
    Table 44. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units) by Application (2017-2022)
    Table 45. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)
    Table 46. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Share by Application (2017-2022)
    Table 48. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Price by Application (2017-2022) & (US$/Unit)
    Table 49. Shanxi PUDE Pharmaceutical Corporation Information
    Table 50. Shanxi PUDE Pharmaceutical Description and Business Overview
    Table 51. Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 53. Shanxi PUDE Pharmaceutical Recent Developments/Updates
    Table 54. Chengdu Tiantai Mountain Pharmaceutical Corporation Information
    Table 55. Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview
    Table 56. Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 58. Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates
    Table 59. Beijing SL Pharmaceutical Corporation Information
    Table 60. Beijing SL Pharmaceutical Description and Business Overview
    Table 61. Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 63. Beijing SL Pharmaceutical Recent Developments/Updates
    Table 64. Yaopharma Corporation Information
    Table 65. Yaopharma Description and Business Overview
    Table 66. Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 68. Yaopharma Recent Developments/Updates
    Table 69. Sinopharm Guorui Pharmaceutical Corporation Information
    Table 70. Sinopharm Guorui Pharmaceutical Description and Business Overview
    Table 71. Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 73. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
    Table 74. Reyoung Pharmaceutical Corporation Information
    Table 75. Reyoung Pharmaceutical Description and Business Overview
    Table 76. Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 78. Reyoung Pharmaceutical Recent Developments/Updates
    Table 79. Fujian Mindong Rejuenation Pharmaceutical Corporation Information
    Table 80. Fujian Mindong Rejuenation Pharmaceutical Description and Business Overview
    Table 81. Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 83. Fujian Mindong Rejuenation Pharmaceutical Recent Developments/Updates
    Table 84. Chongqing Lummy Pharmaceutical Corporation Information
    Table 85. Chongqing Lummy Pharmaceutical Description and Business Overview
    Table 86. Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 88. Chongqing Lummy Pharmaceutical Recent Developments/Updates
    Table 89. Youcare Pharmaceutical Corporation Information
    Table 90. Youcare Pharmaceutical Description and Business Overview
    Table 91. Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 93. Youcare Pharmaceutical Recent Developments/Updates
    Table 94. Haikou Qili Pharmaceutical Corporation Information
    Table 95. Haikou Qili Pharmaceutical Description and Business Overview
    Table 96. Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 98. Haikou Qili Pharmaceutical Recent Developments/Updates
    Table 99. Harbin Medisan Pharmaceutical Corporation Information
    Table 100. Harbin Medisan Pharmaceutical Description and Business Overview
    Table 101. Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 103. Harbin Medisan Pharmaceutical Recent Developments/Updates
    Table 104. Hainan Hualon Pharmaceutical Corporation Information
    Table 105. Hainan Hualon Pharmaceutical Description and Business Overview
    Table 106. Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 108. Hainan Hualon Pharmaceutical Recent Developments/Updates
    Table 109. Anhui Hongye Pharmaceutical Corporation Information
    Table 110. Anhui Hongye Pharmaceutical Description and Business Overview
    Table 111. Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 113. Anhui Hongye Pharmaceutical Recent Developments/Updates
    Table 114. Guangzhou Invin Pharmaceutical Corporation Information
    Table 115. Guangzhou Invin Pharmaceutical Description and Business Overview
    Table 116. Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product
    Table 118. Guangzhou Invin Pharmaceutical Recent Developments/Updates
    Table 119. Production Base and Market Concentration Rate of Raw Material
    Table 120. Key Suppliers of Raw Materials
    Table 121. Potassium Sodium Dehydroandrographolide Succinate for Injection Distributors List
    Table 122. Potassium Sodium Dehydroandrographolide Succinate for Injection Customers List
    Table 123. Potassium Sodium Dehydroandrographolide Succinate for Injection Market Trends
    Table 124. Potassium Sodium Dehydroandrographolide Succinate for Injection Market Drivers
    Table 125. Potassium Sodium Dehydroandrographolide Succinate for Injection Market Challenges
    Table 126. Potassium Sodium Dehydroandrographolide Succinate for Injection Market Restraints
    Table 127. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Specification (2023-2028) & (K Units)
    Table 128. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Forecast by Specification (2023-2028)
    Table 129. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Specification (2023-2028) & (US$ Million)
    Table 130. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Specification (2023-2028)
    Table 131. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Application (2023-2028) & (K Units)
    Table 132. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Forecast by Application (2023-2028)
    Table 133. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 134. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Application (2023-2028)
    Table 135. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Region (2023-2028) & (K Units)
    Table 136. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Forecast by Region (2023-2028)
    Table 137. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 138. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Region (2023-2028)
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Potassium Sodium Dehydroandrographolide Succinate for Injection
    Figure 2. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Share by Specification in 2021 & 2028
    Figure 3. 40mg/Bottle Product Picture
    Figure 4. 80mg/Bottle Product Picture
    Figure 5. 200mg/Bottle Product Picture
    Figure 6. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy
    Figure 8. Retail Pharmacy
    Figure 9. Others
    Figure 10. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (2017-2028) & (K Units)
    Figure 13. Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Share by Manufacturers in 2021
    Figure 14. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Potassium Sodium Dehydroandrographolide Succinate for Injection Players: Market Share by Revenue in 2021
    Figure 16. Potassium Sodium Dehydroandrographolide Succinate for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region (2017-2022)
    Figure 18. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region in 2021
    Figure 19. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Region (2017-2022)
    Figure 20. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Region in 2021
    Figure 21. United States Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Colombia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Potassium Sodium Dehydroandrographolide Succinate for Injection by Specification (2017-2022)
    Figure 45. Manufacturing Cost Structure of Potassium Sodium Dehydroandrographolide Succinate for Injection
    Figure 46. Manufacturing Process Analysis of Potassium Sodium Dehydroandrographolide Succinate for Injection
    Figure 47. Potassium Sodium Dehydroandrographolide Succinate for Injection Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed